P/E ratio for SurgePays (SURG)

P/E ratio history for SurgePays from 2018 to 2026

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Johnson & Johnson JNJ	42.9	-35,998.91%	🇺🇸 USA
Novartis NVS	30.5	-25,681.45%	🇨🇭 Switzerland
Stryker Corporation SYK	32.8	-27,531.77%	🇺🇸 USA
Cooper Companies COO	21.1	-17,762.56%	🇺🇸 USA
STAAR Surgical STAA	N/A	N/A	🇺🇸 USA
CONMED CNMD	20.9	-17,564.35%	🇺🇸 USA
Integra LifeSciences IART	86.3	-72,373.96%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.